Department of Surgery, University of California Irvine Medical Center, Orange, CA 92868, USA.
J Gastrointest Surg. 2011 Nov;15(11):1952-60. doi: 10.1007/s11605-011-1658-8. Epub 2011 Sep 9.
Gastrointestinal leak is a dreaded complication after esophagectomy. Conventional treatments for leak include conservative therapy, surgical reoperation, and even complete gastrointestinal (GI) diversion. The aim of this study was to evaluate the impact of endoluminal stenting in the management of esophagogastric leak after esophagectomy.
Data on 18 (11.3%) of 160 patients who developed postoperative leaks after minimally invasive esophagectomy were reviewed. Indications for esophagectomy included carcinoma (n = 14), Barrett's with high-grade dysplasia (n = 3), and benign stricture (n = 1). Neoadjuvant therapy was used in 57.1% of patients with carcinoma. The first nine patients underwent conventional treatments for leak whereas the latter nine patients underwent endoscopic esophageal covered stenting as primary therapy. There were 5 cervical and 13 intrathoracic anastomotic leaks. Main outcome measures included patient characteristics, types of treatment, length of hospital stay, morbidity, and mortality.
Subjects were 16 males and 2 females with a mean age of 66 years. In the conventional treatment group, leaks were treated with neck drainage (n = 4), GI diversion (n = 2), and thoracoscopic drainage with or without repair or T-tube placement (n = 3). In the endoscopy group, all leaks were treated with endoscopic covered stenting with or without percutaneous drainage (n = 9). Control of leaks occurred in 89% of patients in the conventional treatment group vs. 100% of patients in the endoscopic stenting group. Three patients in the conventional treatment group (33%) required esophageal diversion compared to none of the patients in the endoscopy group. The 60-day or in-hospital mortality was 0% for both groups.
In our clinical practice, there has been a shift in the management of esophagogastric anastomotic leaks to nonsurgical therapy using endoscopic esophageal covered stenting. Endoluminal stenting is a safe and effective alternative in the management of GI leaks.
胃肠道漏是食管切除术后一种可怕的并发症。漏的传统治疗包括保守治疗、再次手术,甚至完全胃肠(GI)分流。本研究旨在评估内镜下支架置入在食管切除术后胃食管漏治疗中的作用。
回顾了 160 例微创食管切除术后发生术后漏的患者(18 例,占 11.3%)的数据。食管切除术的适应证包括癌(n=14)、高级别异型增生的 Barrett 食管(n=3)和良性狭窄(n=1)。57.1%的癌患者接受了新辅助治疗。前 9 例患者采用传统方法治疗漏,后 9 例患者采用内镜食管覆膜支架作为主要治疗方法。有 5 例颈部和 13 例胸内吻合口漏。主要观察指标包括患者特征、治疗类型、住院时间、发病率和死亡率。
受试者为 16 名男性和 2 名女性,平均年龄为 66 岁。在传统治疗组中,漏的治疗方法包括颈部引流(n=4)、胃肠分流(n=2)和胸腔镜引流加或不加修补或 T 管放置(n=3)。在内镜组中,所有漏均采用内镜下覆膜支架治疗,加或不加经皮引流(n=9)。传统治疗组 89%的患者漏得到控制,内镜支架组 100%的患者漏得到控制。传统治疗组中有 3 例(33%)患者需要食管分流,而内镜组中无患者需要食管分流。两组 60 天或住院死亡率均为 0%。
在我们的临床实践中,胃食管吻合口漏的治疗已从传统的手术治疗转变为使用内镜食管覆膜支架的非手术治疗。内镜下支架置入是治疗 GI 漏的一种安全有效的替代方法。